EDITOR-IN-CHIEF
editor ial
William S. Hancock Barnett Institute and Department of Chemistry Northeastern University 360 Huntington Avenue 341 Mugar Bldg. Boston, MA 02115 617-373-4881; Fax: 617-373-2855
[email protected] The Promise of 2004
ASSOCIATE EDITORS
Joshua LaBaer Harvard Medical School
György Marko-Varga AstraZeneca and Lund University
EDITORIAL ADVISORY BOARD
Ruedi H. Aebersold Institute for Systems Biology
Leigh Anderson Plasma Proteome Institute
Ettore Appella National Cancer Institute
Rolf Apweiler European Bioinformatics Institute
Ronald Beavis University of Chicago
Walter Blackstock Cellzome
Brian Chait The Rockefeller University
Patrick L. Coleman 3M
Christine Colvis National Institutes of Health
Catherine Fenselau University of Maryland
Daniel Figeys MDS Proteomics
Sam Hanash University of Michigan
Stanley Hefta Bristol-Myers Squibb
Donald F. Hunt University of Virginia
Barry L. Karger Northeastern University
s we move into the year 2004, it is pleasing to note the growth in manuscript submission to the journal, as well as the continued high quality of science. Much of the achievement of the journal can be attributed to the hard work of all of the JPR staff, and so I want to express my appreciation at this time. In the broader community, one of the important accomplishments of 2003 has been the continuing evolution of the Human Proteome Organization (HUPO). Some of the projects under way include the plasma proteome (centered in North America), the brain proteome (Europe), and the liver proteome (Asia). The international collaborations are having a positive impact on many of the fundamental issues underlying proteomics. For example, for the plasma proteome, the key issues focused on collection of a suitable number of patient samples, determination of appropriate storage conditions, and selection of proteomic platforms. This project also exposed the challenges of bioinformatics, particularly when it becomes necessary to compare data produced in many laboratories on diverse hardware systems. In 2004 it is appropriate to highlight another tremendous challenge: the characterization of the liver proteome. Not surprisingly, our Asian colleagues are focusing on this proteome because of health concerns regarding hepatitis. With this valuable endeavor in mind, the journal has selected a key protein in the replication of hepatitis C virus for its 2004 cover. We hope that this journal cover will thus act as a catalyst for research in this important field for 2004. This proteomics endeavor will also contribute to other HUPO initiatives, as many of the proteins in blood are secreted from the liver. In addition, many of the early issues involving sample collection and storage, proteomic platforms, and bioinformatics will be highlights of this project. Other items on the HUPO agenda for 2004 include reporting the initial results of characterizing the plasma proteome and the Third Annual World Congress, which appropriately will be held October 25–28 in Beijing. There will be many other significant proteomic programs in 2004, but HUPO serves as a good model for international collaborations on a large scale. I look forward to continuing success for the journal this year and welcome your comments, manuscript submissions, and particularly your highquality reviews.
A
Daniel C. Liebler Vanderbilt University School of Medicine
Lance Liotta National Cancer Institute
Matthias Mann University of Southern Denmark
Stephen A. Martin Applied Biosystems
Jeremy Nicholson Imperial College of London
Gilbert S. Omenn University of Michigan
Emanuel Petricoin Food and Drug Administration
J. Michael Ramsey Oak Ridge National Laboratory
Pier Giorgio Righetti University of Verona
John T. Stults Biospect
Peter Wagner Zyomyx
Keith Williams Proteome Systems
Qi-Chang Xia Shanghai Institute of Biochemistry
John R. Yates, III The Scripps Research Institute
© 2004 American Chemical Society
Journal of Proteome Research • Vol. 3, No. 1, 2004
11
